The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...

Inogen faces margin pressure and slow growth; divestment may lift income and buybacks. Click to read this latest analysis of ...

Inogen, Inc. INGN incurred an adjusted loss per share of 15 cents for fourth-quarter 2025, which was narrower than the adjusted loss per share of 24 cents in the year-ago period and the Zacks ...

The company's vision is to be a leader in the migration to more portable oxygen delivery systems. It offers several products towards that end. The stock has doubled over the past year, but the shares ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Inogen (INGN) shares soared 5.1% in the last trading session to close at $27.82. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

(Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has signed a definitive agreement to divest its U.S.

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of its high prospects in the portable oxygen concentrator (POC) space. The optimism led by solid second-quarter 2023 and a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...